| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |